山东威高集团医用高分子制品股份有限公司（01066）于2025年12月1日披露11月股份变动月报。报告期为2025年11月1日至11月30日，公司法定注册股本维持人民币457,063,232.4元不变，其中包括已在香港联合交易所上市的H股和非上市普通股。
本月H股已发行股份（不含库存股）由期初的4,500,049,524股降至4,495,116,324股，减少4,933,200股；对应库存股由22,282,800股增加至27,216,000股，增加数量同为4,933,200股。非上市普通股数量48,300,000股维持不变。各种股份总数保持4,522,332,324股不变。
根据公告，11月内公司多次以每股约5.27至5.63港元的价格回购H股，累计回购493.32万股并全部转为库存股，暂无注销安排。无新增发行或其他类型股份变动，亦无股份期权、可转换债券或其他衍生工具涉及本期增减。
公司披露已严格遵守香港联交所《上市规则》及相关法律法规。该份月报由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.